Remeditex Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Remeditex Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 18, 2017	Rodin Therapeutics	$27.0M Other Equity	—	Bruce Booth, Ben Robbins, Clay B. Thorp, John Creecy, Jason Hong
Jul 1, 2017	VYNE Therapeutics	$51.0M Series C	—	venBio, Aisling Capital, Bay City Capital, F-Prime Capital, Novo Holdings, Presidio Partners, Rock Springs Capital, Vivo Capital
Sep 1, 2016	Peloton Therapeutics	$52.0M Series D	Jim Tananbaum	The Column Group, Nextech Invest, Tichenor Ventures, Topspin Fund
Dec 1, 2015	Navitor Pharmaceuticals	$33.0M Series B	Vinzenz Ploerer	Endeavor Venture Funds, Polaris Partners, Venrock, Atlas Venture, Johnson & Johnson Innovation, Polaris Partners, Barry Burgdorf, Sanofi Ventures, SR One
Nov 1, 2015	Viridian Therapeutics	$41.0M Series C	Jafco Ventures, Joshua Resnick	Atlas Venture, MPM Capital, Amgen Ventures, Boulder Ventures, Brace Pharma Capital, MP Healthcare Venture Management
Oct 7, 2015	Quartet Medicine	$6.3M Series A Extension	John Creecy	—
Aug 27, 2014	Bellicum Pharmaceuticals	$55.0M Series C	—	AJU IB Investment, AVG Ventures, Jennison Associates, Joseph Edelman, RA Capital Management, Redmile Group, Ridgeback Capital Investments, Sabby Capital
Jan 7, 2014	Bellicum Pharmaceuticals	$14.7M Series B Extension	—	AVG Ventures
Sep 8, 2012	Bi02 Medical	$12.0M Series C	Remeditex Ventures	—
Apr 1, 2012	Viridian Therapeutics	$20.0M Series B	John Creecy	Atlas Venture, Broadview Ventures, MPM Capital, Amgen Ventures, Boulder Ventures, Broadview Ventures
Mar 8, 2012	Bellicum Pharmaceuticals	$20.0M Series B	—	James Earl "Jim" Brown III, AVG Ventures, Dennis Stone
Jul 1, 2011	Peloton Therapeutics	$18.0M Series A	The Column Group	John Creecy